Results 181 to 190 of about 1,754,517 (342)
Current and future diagnostics of congenital heart disease (CHD). [PDF]
Hitz MP, Dombrowsky G, Melnik N, Vey C.
europepmc +1 more source
Exosomes can reduce tissue damage in temporomandibular joint osteoarthritis (TMJOA), but rapid clearance limits their efficacy. This study encapsulates exosomes in hyaluronic acid hydrogels for controlled release. In a rat model, hydrogel‐encapsulated exosomes outperform free exosomes in preserving bone integrity and reducing tissue destruction ...
Victor Diez‐Guardia+7 more
wiley +1 more source
Mechanical Circulatory Support in Congenital Heart Disease. [PDF]
Lynch Á, Jeewa A.
europepmc +1 more source
Schematic illustration of the mechanism of targeted delivery of nanoparticles including 1) paracellular, 2) endolysosomal escape, 3) receptor mediated endocytosis, and 4) M cell mediated transport for non‐GI diseases by oral administration such as atherosclerosis, cancer, diabetes, and brain diseases. Abstract Oral drug delivery is a promising approach
Subarna Ray+2 more
wiley +1 more source
Kinesiophobia in patients with coronary heart disease: a Rodgers' evolutionary concept analysis. [PDF]
Zhang MJ+4 more
europepmc +1 more source
An Address ON THE MANAGEMENT OF CASES OF ADVANCED HEART DISEASE: Read before the Gloucestershire Branch of the British Medical Association on May 17th, 1906 [PDF]
R. Saundby
openalex +1 more source
Deinococcus radiodurans‐derived extracellular vesicles (R1‐EVs) provide radioprotection against total‐body irradiation‐induced acute radiation syndrome in mice. R1‐EVs mitigate oxidative damage by scavenging free radicals, promoting intestinal repair, enhancing hematopoietic function, and modulating immune responses. This study highlights the potential
Jeong Moo Han+7 more
wiley +1 more source
Mitochondrial Dysfunction in Congenital Heart Disease. [PDF]
Pires Da Silva J+3 more
europepmc +1 more source